Antioxidant and antiproliferative effects of flavonoid fractions from Citri Exocarpium Rubrum on A549 lung cancer cells and their underlying mechanisms by network pharmacology

Lung cancer remains a leading cause of cancer mortality, with chemotherapy resistance limiting treatment efficacy. Citri Exocarpium Rubrum (CER), a flavonoid-rich traditional Chinese medicine, exhibits anticancer potential. This study investigated its antioxidant and antiproliferative effects against A549 lung cancer cells and the underlying mechanisms. Flavonoids were extracted from CER and partitioned into ethyl acetate and n-butanol fractions. Antioxidant capacity and antiproliferative effects were assessed by 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays, respectively. Mitochondrial membrane potential (MMP) and apoptosis were measured. Network pharmacology was conducted using TCMSP, SwissTargetPrediction and GeneCards, followed by GO and KEGG enrichment analyses. Both fractions showed concentration-dependent DPPH radical scavenging (73.66% and 84.36% at 32 μg/mL) and inhibited A549 proliferation. The n-butanol fraction induced dose-dependent apoptosis with reduced MMP. Network pharmacology identified 6 active components, 255 targets, 5 hub targets (SRC, ESR1, BCL2, HSP90AA1, PPARG) and 20 enriched pathways related to cancer and calcium signalling. CER flavonoid fractions demonstrate antioxidant and antiproliferative activities against A549 cells via multi-component, multi-target mechanisms, supporting its potential clinical application in lung cancer therapy.

Authors

Institutions

Publication Details

Journal
Natural Product Research
Published
2026-11-17
DOI
https://doi.org/10.1080/14786419.2026.2762517
Primary Topic
Flavonoids in Medical Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Antioxidant and antiproliferative effects of flavonoid fractions from Citri Exocarpium Rubrum on A549 lung cancer cells and their underlying mechanisms by network pharmacology

Haixiao LU, Guofang Zeng, Shiyuan Zeng, Min Wei et al.
Natural Product Research
Flavonoids in Medical Research
article

Antioxidant and antiproliferative effects of flavonoid fractions from Citri Exocarpium Rubrum on A549 lung cancer cells and their underlying mechanisms by network pharmacology

Haixiao LU, Guofang Zeng, Shiyuan Zeng, Min Wei, Jinling Wang, Yukai Chen
article en

Abstract

Lung cancer remains a leading cause of cancer mortality, with chemotherapy resistance limiting treatment efficacy. Citri Exocarpium Rubrum (CER), a flavonoid-rich traditional Chinese medicine, exhibits anticancer potential. This study investigated its antioxidant and antiproliferative effects against A549 lung cancer cells and the underlying mechanisms. Flavonoids were extracted from CER and partitioned into ethyl acetate and n-butanol fractions. Antioxidant capacity and antiproliferative effects were assessed by 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays, respectively. Mitochondrial membrane potential (MMP) and apoptosis were measured. Network pharmacology was conducted using TCMSP, SwissTargetPrediction and GeneCards, followed by GO and KEGG enrichment analyses. Both fractions showed concentration-dependent DPPH radical scavenging (73.66% and 84.36% at 32 μg/mL) and inhibited A549 proliferation. The n-butanol fraction induced dose-dependent apoptosis with reduced MMP. Network pharmacology identified 6 active components, 255 targets, 5 hub targets (SRC, ESR1, BCL2, HSP90AA1, PPARG) and 20 enriched pathways related to cancer and calcium signalling. CER flavonoid fractions demonstrate antioxidant and antiproliferative activities against A549 cells via multi-component, multi-target mechanisms, supporting its potential clinical application in lung cancer therapy.

Natural Product Research
Yulin Normal University (CN)
Yulin Normal University
Good health and well-being
Flavonoids in Medical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon